Cyprus · Delayed Price · Currency is EUR IDNA Genomics Public Statistics
Total Valuation
CYS:IDNA has a market cap or net worth of EUR 80.05 million. The enterprise value is 82.17 million.
| Market Cap | 80.05M |
| Enterprise Value | 82.17M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CYS:IDNA has 2.76 million shares outstanding.
| Current Share Class | 2.76M |
| Shares Outstanding | 2.76M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 85.00% |
| Owned by Institutions (%) | 2.18% |
| Float | 414,050 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 156.13 |
| PB Ratio | -49.13 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -32.72 |
| EV / Sales | 160.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -29.65 |
Financial Position
The company has a current ratio of 0.29
| Current Ratio | 0.29 |
| Quick Ratio | 0.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.91 |
| Interest Coverage | -8.59 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 244.54% |
| Revenue Per Employee | 24,414 |
| Profits Per Employee | -119,582 |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CYS:IDNA has paid 12,078 in taxes.
| Income Tax | 12,078 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.41% in the last 52 weeks. The beta is 0.00, so CYS:IDNA's price volatility has been lower than the market average.
| Beta (5Y) | 0.00 |
| 52-Week Price Change | +7.41% |
| 50-Day Moving Average | 27.55 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 66.86 |
| Average Volume (20 Days) | 120 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CYS:IDNA had revenue of EUR 512,704 and -2.51 million in losses. Loss per share was -0.91.
| Revenue | 512,704 |
| Gross Profit | 10,192 |
| Operating Income | -1.67M |
| Pretax Income | -3.19M |
| Net Income | -2.51M |
| EBITDA | -1.64M |
| EBIT | -1.67M |
| Loss Per Share | -0.91 |
Balance Sheet
The company has 167,613 in cash and 2.52 million in debt, giving a net cash position of -2.36 million or -0.85 per share.
| Cash & Cash Equivalents | 167,613 |
| Total Debt | 2.52M |
| Net Cash | -2.36M |
| Net Cash Per Share | -0.85 |
| Equity (Book Value) | -1.63M |
| Book Value Per Share | -0.50 |
| Working Capital | -2.28M |
Cash Flow
In the last 12 months, operating cash flow was -2.76 million and capital expenditures -9,680, giving a free cash flow of -2.77 million.
| Operating Cash Flow | -2.76M |
| Capital Expenditures | -9,680 |
| Free Cash Flow | -2.77M |
| FCF Per Share | -1.00 |
Margins
| Gross Margin | 1.99% |
| Operating Margin | -325.63% |
| Pretax Margin | -622.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CYS:IDNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.14% |
| FCF Yield | -3.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CYS:IDNA has an Altman Z-Score of 6.8.
| Altman Z-Score | 6.8 |
| Piotroski F-Score | n/a |